Ergoteles’s Vaxart VXRT Stock Holding History

Ergoteles’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-168,791	Closed	-$128K	–	1561
2023 Q1	$128K	Sell	168,791 -871,857	-84%	-$810K	0.01%	1081
2022 Q4	$1,000K	Buy	+1,040,648	New	+$1.47M	0.04%	457
2022 Q1	–	Sell	-145,581	Closed	-$913K	–	1657
2021 Q4	$913K	Buy	+145,581	New	+$994K	0.04%	442

Other funds holding VXRT

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Ergoteles's VXRT Position: Q2 2023 in Review

Ergoteles sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 168,791 shares — an estimated $128K sold.

Ergoteles first reported a position in VXRT in Q4 2021 and held it in 3 quarters. The position peaked at $1,000K in Q4 2022. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

Ergoteles reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 168,791 Vaxart shares in Q2 2023, an estimated $128K.
Ergoteles first reported a position in Vaxart in Q4 2021 and held it in 3 quarters.
Ergoteles's Vaxart position peaked at $1,000K in Q4 2022.
111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.